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Receptors of the integrin family are largely confined 
to the basal layer of keratinocytes, both in human 
epidermis and in stratified cultures of human kerati-
nocytes. However, suprabasal integrin expression is 
observed during epidermal wound healing and in 
psoriatic lesions. We have investigated potential 
stimuli of suprabasal expression. Addition of trans-
forming growth factor-f3 (TGF-f3), interferon-1' (IFN-
1'), or tumor necrosis factor-a (TNF-a) to keratino-
cytes cultured with a 3 T3 feeder layer did not induce 
suprabasal expression. The cytokines caused small 
changes in the levels of a 2f3 1 or a 3f3 1 on the surface of 
basal keratinocytes but had no significant effect on 
the proportion of cells adhering to fibronectin, type 
IV collagen, and laminin, and did not cause changes 
in the mobility of integrin subunits on polyacryl-
amide gels. Injection of TNF-a or IFN-1' intrader-
mally into healthy human volunteers induced an 
ntegrins are a! f3 heterodimeric adhesive receptors that are 
expressed on most cell types and have a variety of functions 
[1]. Cultured human keratinocytes express several integrins 
with a common f3 subunit, including a 2f31' which mediates 
binding to collagen and laminin; a 3f31' a receptor for 
laminin and epiligrin; and a sf31' the fibronectin receptor [2- 6]. 
Keratinocytes also express a v f3 s, which is a vitronectin receptor 
[5,7], and a 6 f3 4' a component of hemidesmosomes, the ligand for 
which remains to be established unequivocally in keratinocytes 
[5,8-10]. Experiments with cultured keratinocytes have demon-
strated that inte grin s have a number of functions within the 
epidermis. They not only mediate keratinocyte adhesion to extra-
cellular matrix proteins, but also play a role in lateral migration, 
stratifIcation, the regulation of terminal differentiation [2,11- 13], 
and intercellular adhesion ([3,14,15], but see also [16]). Further-
more, basal keratinocytes with characteristics of stem cells can be 
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inflammatory response but did not induce suprabasal 
integrin expression. However, we did observe tran-
sient suprabasal integrin expression when keratino-
cytes were grown on a dermal equivalent consisting 
of fibroblasts in a collagen gel. One week after raising 
the cultures to the air-liquid interface, 131 integrins 
were found in all the viable cell layers, with supra-
basal cells co-expressing integrins and involucrin; 1 
week later integrins were confined to the basal layer . 
Addition of TGF-f3, IFN-1', or TNF-a to the dermal 
equivalents neither induced nor inhibited suprabasal 
integrin expression. We conclude that suprabasal 
integrin expression is not induced by the inflamma-
tory cytokines tested, and instead may reflect the 
proliferation/differentiation status of the epidermis. 
Key words: differentiation/inflammation/proliferation/ adhe-
sion. ] Invest Dermatol 104:260-265, 1995 
isolated on the basis of high surface expression of the f3 1 integrins 
[1 7]. 
Integrin expression is normally confin ed to the basal layer of 
keratinocytes, both in vivo and in stratified cultures [5 ,18-22]. 
However, suprabasal integrin expression has been observed during 
epidermal wound healing [22,23] and in certain disease states. In 
wound healing, suprabasal expression is transient: co-expression of 
integrins and specific markers of terminal differentiation is observed 
at the time of w ound closure, when the epidermis is hyperprolif-
erative, but is absent 1 week larer [22]. Suprabasal expression also 
has been noted in benign hyperproliferative disorders: in psoriatic 
lesions [22,24 - 27], eczema, and lichen planus [26]. 
To understan d the significan ce of suprabasal integrin expression 
in the epidermis, we h ave begun to investigate poten tial stimuli. 
Release of cytokines by th e inflammatory infiltrate characteristic of 
psoriatic lesions and woun ds has been well documented [28,29]. 
Cytokines regulate many aspects of keratinocyte behavior, includ-
ing proliferation [30,31 ], migration [32,33], and communication 
with cells of the immune system [28]. Tn addition, specific cytokines 
h ave been shown to up-regulate integrin expression in a range of 
cell types [3 4-41]. W e selected three cytokines for study-
interferon-y (IFN-y), transforming growth factor-f3 (TGF-f3) , and 
tumor necrosis factor-a (TNF-a)-because of their reported presence 
or up-regulation in inflamed skin [28,42,43] , their effects on integrin 
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expression [35,36,38,39], and their ability to influence keratinocyte 
proliferation and/or terminal differentiation [31,44 - 47]. 
We report that, in contrast to expectations, IFN-')', TGF-J3, and 
TNF-a did not induce suprabasal expression and had only modest 
effects on integrin expression by basal keratinocytes. However, if 
keratinocytes were cultured under standard conditions on a dermal 
equivalent, transient suprabasal expression was observed. 
MA TERIALS AND METHODS 
Cell Cultures for Cytokine Treatments Human epidermal keratino-
cytes from neonatal foreskins (strains kc, kd, kf, kk, and z, passage numbers 
3-5) were cultured in the presence of a feeder layer of mitomycin-C-treated 
3T3-J2 cells, as described previously [48]. The culture medium consisted of 
one part Ham's F12 medium and three parts Dulbecco's modification of 
Eagle's medium supplemented with 1.8 X 10- 4 M adenine (FAD). 10% fetal 
bovine serum (FBS), 0.5 /Lg/ml hydrocortisone, 5 /Lg/ml insulin, 10- 10 M 
cholera toxin and 10 ng/ml epidermal growth factor (HICE) (FAD + 
FBS + HICE). 
Preconfluent cultures were treated with cytokines in FAD + FBS + 
HICE for 24 or 48 h. Human recombinant IFN-y was a generous gift of I. 
Kerr (Imperial Cancer Research Fund [ICRF]). Human TGF-f31 was 
obtained from the National Reference Standards Laboratory (South 
Mimms, Herts, UK) or from Sigma Chemical Co. (Poole, UK). Human 
recombinant TNF-a was obtained from the National Reference Standards 
Laboratory or was generously provided by F. Balkwill (ICRF). 
Sheets of keratinocytes were harvested with 2.5 mg/ml Dispase 1-5 d 
post-confluence, as described previously [49], and frozen in an isopentane 
bath in liquid nitrogen. Six-micrometer frozen sections were prepared using 
a cryostat. 
Immunofluorescence Staining of Sections The primary antibodies 
(mouse monoclonals) used were as follows: HAS4 (anti-a2 [16]), VM-2 
(anti-a3 [50]), anti-CD29 (anti-f31; Janssen, UK), P5D2 (anti-f31; Develop-
mental Studies Hybridoma Bank [51]), and 15.2 (anti-intercellular adhesion 
molecule-1 [ICAM-1]; gift of N. Hogg; ICRF [52]). Primary antibodies 
were detected with fluorescein isothiocyanate (FITC)-conjugated anti-
mouse IgG (Sigma; Zymed, South San Francisco, CA; or Jackson Immu-
noResearch Laboratories Inc., West Grove, PA) or biotinylated anti-mouse 
IgG followed by FITC-streptavidin (Amersham International, UK). 
Sections were stained essentially as described previously [21,22] . Briefly, 
sections were fixed for 30 min in 4(Yo formaldehyde in phosphate-buffered 
saline (PBS) containing 1 mM magnesium chloride and 1 mM calcium 
chloride (PBS ABC), blocked in 0.1 M glycine in PBS ABC, and incubated 
for 30 min in PBS ABC containing 0.1 % bovine serum albumin (BSA) , 
0.02% Triton X-100 (PBS/BSA/Triton), to which 0.02% sodium azide was 
added as preservative. The first antibody was applied for 1 h at room 
temperature, and then sections were washed three times over a period of 
45-60 min in PBS/BSA/Triton. The second antibody was added, and 
sections were incubated and washed as before. Finally, sections were 
mounted in DABCO mounting medium . Controls consisted of omitting 
each primary antibody. 
In some experiments, we performed double-label immunofluorescence 
for f31 integrins and involucrin. The f31 subunit was detected with P5D2 and 
involucrin with a rabbit polyclonal antiserum, DH1 [53] . Unfixed frozen 
sections were incubated with a mixture of P5D2 and DH1, rinsed thor-
oughly in PBS containing 0.1 % BSA and 0.05% Tween 20, then incubated 
with a mixture ofFITC-conjugated sheep anti-mouse IgG Qackson Immuno-
Research Laboratories) and RITC-conjugated goat anti-rabbit IgG and 
washed as before. 
Flow Cytometry Preconfluent keratinocyte cultures were harvested 
with trypsin/ethylenediamine tetraacetic acid, washed in serum-containing 
medium, and resuspended in cold PBS ABC (4°C) containing the appro-
priate antibody. Antibodies used were FITC conjugates of anti-CD29, 
HAS4, VM-2, and anti-CD8 (Sigma). (CD8 is involved in major histocom-
patibility complex class I-restricted antigen recognition and is not expressed 
by keratinocytes; the antibody was used as a control for nonspecific 
binding.) Cells were incubated with antibodies for 20-30 min on ice, 
washed in cold PBS ABC, and analyzed in a FACScan Flow Cytometer, 
acquiring 10,000 events per sample with settings determined previously for 
keratinocytes [17]. Propidium iodide, 50 /Lg/ml, was added to samples 
immediately before analysis so that dead cells could be gated out. 
Basal keratinocytes can be distinguished from suprabasal, terminally 
differentiating cells on the basis of their forward and side light-scatter 
characteristics [17]. The fluorescence of cytokine-treated basal keratino-
cytes was compared with that of control basal cells by normalizing the 
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modal fluorescence values; data are expressed as percentage differences in 
fluorescence. 
Immunoprecipitation Preconflu nt cultures of keratinocytes were la-
beled overnight with 50 /LCi/ml 3SS-methionine and cysteine (TranS3S_ 
Label, ICN; specific activity 1180 Ci/mmol) in FAD + FBS + HICE, then 
extracted and irnmunoprecipitated as described previously [5,12]. The lysis 
buffer consisted of 150 ruM sodium chloride, 1% Nonidet P-40, 50 roM 
Tris-HCI pH 7.5, 0.1 mg/ml leupeptin, and 2 mM phenylmethylsulfonyl 
fluoride. Lysates containing 106 trichloroacetic-acid-precipitable counts 
were incubated with anti-CD29 for at least 90 min on ice and then mixed, 
end over end, at 4°C with protein A Sepharose (Pharmacia) for at least 60 
min. The beads were recovered, washed, and resuspended in polyacryl-
amide gel electrophoresis sample buffer (non-reducing). Samples were 
electrophoresed on 7.5% polyacrylamide gels using the buffer system of 
Laemmli [54]. Gels were stained with Coomassie blue, destained, incubated 
in Amplify (Amersham International), dried down, and exposed to XAR-5 
film (Kodak). 
Adhesion Assays Bacteriologic 96-well plates (Linbro, Flow Laborato-
ries, McLean, V A) were coated with 10 /Lg/ml extracellular matrix (ECM) 
proteins, essentially as described by Adams and Watt [5]. Laminin from the 
Engelbreth-Holm-Swarm murine sarcoma and human placental type IV 
collagen were purchased from Sigma. Human plasma fibronectin was 
obtained from BioProducts Laboratory (Elstree, UK). ECM proteins were 
diluted in PBS ABC and incubated in the 96-well plates overnight at 4°C. 
Mter coating, plates were washed three times in PBS ABC and blocked with 
0.5 mg/ml heat-denatured BSA (fraction V , Ig-free, Sigma) for 1-2 h at 
37°C . Keratinocytes were harvested in trypsin/ethylenediamine tetraacetic 
acid (after removal of 3T3-J2) and washed in 1 mg/ml soybean trypsin 
inhibitor (Sigma), then plated in serum-free FAD at a density of 103 
(fibronectin, type IV collagen) or 104 (laminin) cells per well in triplicate 
wells and incubated at 37°C for 3 h . Nonadherent cells were removed, and 
adherent cells were fixed for 45 min in 4% formaldehyde in PBS ABC at 
room temperature. Plates were rinsed three times in PBS ABC and stained 
with 1% methylene blue in PBS for 45-60 min at room temperature. Plates 
were washed twice with distilled water and air-dried. Three or five fields 
per well were counted using a graticule, and results were expressed as a 
percentage of the number of cells plated per well. The number of cells that 
adhered to heat-denatured BSA in the absence of ECM proteins was 
subtracted from the results. 
In Vivo Injection of Cytokines Volunteers received intradermal injec-
tions to one buttock of either 10 /Lg IFN-y (specific activity 1 X 107 U/mg, 
kind gift of Biogen Inc., Cambridge, MA) or 100 U recombinant human 
TNF-a (kind gift of Knoll AG, Ludwigshafen, Germany) and were biopsied 
at 6 h (TNF-a), 24 h (IFN-y), or 48 h (IFN-y). An additional group 
received three daily injections of IFN-y (10 /Lg) or TNF-a and were 
biopsied 2 d after the final injection (i.e., day 5) . In all volunteers, PBS was 
injected to the contralateral buttock in identical manner as a control. 
Six-millimeter punch-biopsy specimens were obtained from cytokine-
injected and control sites under local anesthesia, snap frozen, and stored in 
liquid nitrogen before immunostaining. At least three volunteers in each 
group were studied. The study was carried out with the approval of Guy's 
Hospital Ethical Committee and with the informed consent of the volun-
teers. 
Dermal Equivalent Cultures Dermal equivalents consisted either of a 
gel of 2.3 mg/ml bovine dermal collagen (Vitrogen; Collagen Corp., 
Freemont, CA) containing 3T3-J2 cells or human dermal fibroblasts, or a 
collagen-coated membrane insert (Cellagen, ICN) with 3T3-J2 cells or 
human dermal fibroblasts seeded on the undersurface. Cultures on collagen 
gels contracted during the course of the experiments, whereas cultures on 
collagen membranes did not. Keratinocytes were seeded immediately after 
the equivalent was prepared or 1 d later; the same results were obtained in 
each case. Keratinocytes were seeded at a density of 105 per 8 cm2 of dermal 
equivalent and grown to confluence submerged in FAD + FBS + HICE. 
Thereafter, cultures were raised to the air-medium interface for 1 or 2 
weeks; in the case of the collagen gels, this was achieved by placing them on 
a stainless-steel grid. These methods are based on those described by other 
workers [55,56]. Dermal equivalent cultures were frozen in an isopentane 
bath cooled in liquid nitrogen; 6-/Lm sections were prepared and stained as 
described above. 
RESULTS 
IFN-'¥, TGF-13, and TNF-a Treatment Results in Small 
Ch~nges in 131 Integrin Levels in Culture Keratinocytes 
cultured according to the Rheinwald and Green technique [48] 
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Figure 1. IFN-')' does not induce suprabasal integrin expression 
and has a small effect on integrin levels in basal keratinocytes. a,b) 
Sections of Rheinwald and Green cultures stained with antibody to the f31 
integrin subunit by immunofluorescence. a) Control; b) treated with 200 
U/ml IFN-)' for 5 d. Bar, 50 IJ.m . c-j) Flow cytometry profiles ofkeratinocytes 
stained with antibodies to the following antigens: c) CD8 (negative control); d) 
a 2 ; e) a 3 ; j) f31 integrin subunits. Dotted lines show keratinocytes treated with 
200 U/ml IFN-)' for 24 h. Solid lines show control (untreated) keratinocytes. 
Vertical axes, cell number; horizontal axes, fluorescence in arbitrary units on a 
log scale. 
with a 3T3 feeder layer were treated with IFN-)' (200 or 500 
U/ml), TGF-J3 (lor 10 ng/ml), or TNF-a (10 or 50 ng/ml) for 24 
h or 48 h, and the effects of the cytokines on integrin expression and 
function were determined. As reported previously [57,58] , 
ICAM-l was induced with both concentrations ofIFN-), (data not 
shown). 
None of the cytokines induced suprabasal integrin expression at 
either time point examined. Sections through confluent cultures 
showed no differences in 131 integrin distribution, with strong 
staining in the basal layer and weak or undetectable staining of the 
suprabasal cells (Fig 1a,b and results not shown). 
Flow cytometric analysis revealed that the cytokines had only 
small effects on the level of integrin expression in basal keratino-
cytes (Table I; Fig 1e-f and data not shown) . IFN-)' caused an 
increase in a 3 and 131 fluorescence. TGF-J3 caused an increase in 
levels of the a2 , a3 , and 131 subunits, and TNF-a induced an 
increase in a 2 and 131 fluorescence and a decrease in a 3 fluores-
cence. Metabolic labeling and immunoprecipitation showed no 
differences in the mobility or relative abundance of the mature a 
and 131 integrin subunits or the immature (underglycosylated) 131 
subunit (Fig 2), suggesting that there were no effects of the 
cytokines on post-translational modifications of the 131 integrins 
such as glycosylation. 
In keratinocytes, as in other cell types, integrin function can be 
regulated independently of expression levels [1,2,59]. We therefore 
examined whether any of the cytokines had an effect on the 
proportion of keratinocytes adhering to type IV collagen, laminin, 
or fibronectin. IFN-)" TGF-J3, and TNF-a caused no statistically 
significant increase or decrease in the proportion of keratinocytes 
adhering (Fig 3 and results not shown). Addition of cycloheximide 
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(20 J,Lg/ml) at the time of plating the cells on ECM proteinf 
inhibited protein synthesis by 95% or more and reduced tht 
proportion of adherent cells by between 5% and 10% in bot~ 
control and cytokine-treated keratinocytes (not shown). This sug-
gests that the cytokines did not differentially affect synthesis ofECM 
proteins. 
Suprabasal Integrin Expression is Not Induced by Intrader-
mal Injection of IFN-y or TNF-a Having seen little effect of 
the inflammatory cytokines on integrin expression iti cultured 
keratinocytes, we investigated whether administration in vivo re-
sulted in any changes in integrin expression. Healthy volunteers 
were injected with IFN-)" TNF-a, or PBS (as a control) and were 
biopsied up to 5 d later. Sections were stained with antibodies to the 
a 2 , a 3 , and 131 integrin subunits (Fig 4e-f and results not shown). 
N one of the treatments resulted in any change in keratinocyte 
integrin expression, although ICAM-l was induced by IFN-)' (Fig 
4a,b), as reported previously [60]. 
Suprabasal Integrin Expression Is Observed in Dermal 
Equivalent Cultures Having failed to induce suprabasal inte-
grin expression by treating keratinocytes with cytokines in vitro or in 
vivo, we examined whether there were any other in vitro conditions 
that resulted in suprabasal integrin expression. We prepared cul-
tures in which keratinocytes were seeded on a gel of type I collagen 
containing 3 T3 cells and cultured at the air-medium interface, as 
keratinocytes grown on a dermal equivalent express a greater range 
of morphologic and molecular markers of terminal differentiation 
than do keratinocytes cultured on tissue culture plastic in the 
presence of a 3 T3 feeder layer [61]. We found that in cultures that 
had been raised to the air-medium interface for 1 week, 131 integrins 
could be found in all the living suprabasal layers (Fig 5a,b) . 
However, in cultures maintained for an additional week, integrin 
expression was confined to the basal layer (Fig 5c,d). Substitution 
of primary human dermal fibroblasts for the 3T3 cells in the 
collagen gel did not alter the pattern of integrin expression (not 
shown), nor did using a collagen-coated culture dish insert onto 
which feeders had been plated. 
We also tested the effects ofIFN-), (200 and 500 U/ml), TGF-J3 
(1 and 10 ng/ml), and TNF-a (10 and 50 ng/ml). The cytokines 
were added to the dermal equivalent cultures on days 1, 3, 5, and 
12, and the cultures were examined 48 h later. None of the 
cytokines either induced or suppressed suprabasal integrin expres-
sion (Fig 5e and data not shown). Double-label immunofluores-
cence revealed that suprabasal cells expressing 131 integrins also 
expressed the differentiation marker involucrin (Fig 5eJ). 
DISCUSSION 
The aim of the present experiments was to discover whether 
inflammatory cytokines might be responsible for the induction of 
suprabasal integrin expression that is observed in psoriasis, eczema, 
and wound healing [22-27]. Treatment of Rheinwald and Green 
cultures with TGF-J3, IFN-)" or TNF-a did not induce suprabasal 
expression. The cytokines caused small changes in the levels of 
a 2 J31 or a3J31 on the surface of basal keratinocytes but had no effect 
on the proportion of cells adhering to fibronectin, type IV collagen, 
Table I. Cytokines Have a Small Effect on Integrin 
Expression Levels in KeratinocytesQ 
Cytokine CD8 a 2 a 3 f31 
IFN-)', 200 U/ml o ± 0 o ± 0 20 ± 2 8 ± 2 
IFN-,)" 500 U/ml o ± 0 o ± 0 18 ± 4 16 ± 13 
TGF-f3 o ± 0 31 ± 8 4 ± 2 17 ± 3 
TNF-a o ± 0 17 ± 13 -5 ± 2 13 ± 8 
a The values shown are mean percentage changes in modal fluorescence (represent-
ing basal cells) compared with control (no cytokine treatment) of 80% confluent 
cultures treated for 24 h, ± standard error of the mean. Results are based on three 
experiments with each cytokine. Cells were labeled with antibodies to CD8 (negative 
control) or to the integrin subunits indicated. 
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Figure 2. Cytokines do not affect the mobility or relative abun-
dance of integrin subunits. Immunoprecipitation of {31 integrins from 
metabolically labeled keratinocytes after treatment with cytokines for 24 h. 
Equal trichloroacetic-acid-precipitable counts were immunoprecipitated. 
(Note that (31-associated a subunits are co-precipitated and migrate as a 
single band.) Positions of molecular-weight standards are indicated. 
and laminin, and did not cause changes in the mobility of the 
integrin subunits on polyacrylamide gels. These results are in 
marked contrast to the major changes in integrin expression that are 
induced in other cell types by IFN-y and TGF-{3 [34-36,39,40], 
including a 20-fold increase in transcripts originating from the {31 
proximal promoter in response to TGF-{3 [40]. 
Inflammation involves a complex cascade of events, including 
the interactions of multiple cell types and cytokines [62], so it is not 
altogether surprising that application of individual cytokines to the 
cultures was not sufficient to induce suprabasal integrin expression. 
Nevertheless, in vivo injections of TNF-a or IFN-y, which induce 
a full inflammatory response ([63]; also Groves et aI, submitted), did 
not cause suprabasal expression either. 
However, we did observe suprabasal integrin expression in 
keratinocytes cultured on a dermal equivalent. All the viable cell 
layers stained positive with antibodies to the {31 integrin subunit 1 
week after the cultures were raised to the air-liquid interface. As in 
wound healing [22], suprabasal expression was transient, and by 2 
weeks {31 integrins were confined to the basal layer of the raft 
cultures, as observed by Asselineau et al [56] and Kaur and Carter 
[64]. The distribution of integrins in the rafts was not affected by 
substituting human dermal fibroblasts for 3T3 cells or by adding 
TGF-{3, IFN-y, or TNF-a to the culture medium. 
Weare thus left with the question of what causes suprabasal 
integrin expression. In vivo, it appears to be linked to the prolifer-
ative status of keratinocytes, being seen in situations in which the 
epithelium is hyperproliferative or there is a high turnover rate of 
the keratinocyte population [22,65]. An exception to this is Rhei-
nwald and Green cultures, which have a high proliferative rate 
(average doubling time for cells in exponential growth is 24 h [66]); 
however, it could be argued that the truncation of the terminal-
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Figure 3. Cytokines do not significantly affect keratinocyte adhe-
sion to ECM proteins. Adhesion of keratinocytes to type IV collagen 
(CIV), laminin (LN), and fibronectin (FN) after treatment for 24 h with (1) 
200 U/ml IFN-y; (2) 500 U/ml IFN-y; (3) 1 ng/ml TGF-{3; or (4) 10 ng/ml 
TGF-{3. Results are expressed as a percentage of the number of control 
(untreated) keratinocytes adhering after subtraction of nonspecific adhesion 
to BSA-coated wells, ± standard error of the mean. 
differentiation pathway in these cultures [61] prevents suprabasal 
expression. In this context, it is interesting that Asselineau et al [56] 
found suprabasal integrin expression in 2-week dermal equivalent 
cultures treated with a high concentration (10 - 6 M) of retinoic 
acid; in the same cultures expression of differentiation markers is 
delayed and uncoupled from morphogenesis. It will be worthwhile 
to extend our in vivo analysis of integrin expression to later biopsies 
Figure 4. Cytokines do not induce suprabasal integrin expression 
in vivo. Biopsy specimens of skin of volunteers after intradermal injection of 
cytokines or PBS. The injected material, time of biopsy post-injection, and 
antibodies used for staining were as follows: a) PBS control, anti-ICAM-l; 
b) IFN-y, 2 d, anti-ICAM-1; c) PBS control, anti-a2 ; d) TNF-a, 1 d, 
anti-a2 ; e) IFN-y, 1 d, anti-a3 ; .f) IFN-y, 5 d, anti-{31 ' 
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Figure 5. Integrins can be expressed suprabasally in dermal equiv-
alent cultures. Cultures were stained with anti-f31 antibody. a,b,eJ) 1 
week; c,d) 2 weeks after raising to the air-medium interface . a-d) Control 
cultures; e-j) treated with 10 ng/ml TGF-f3; b,d) Phase-contrast images of 
a,c, respectively. eJ) Double-label immunofluorescence: e) f31;j) involucrin. 
Arrol/lheads (f) denote boundary between keratinocytes and underlying 
collagen gel. Bar, 50 /Lm. 
of IFN-)l-treated skin, as increased keratinocyte proliferation is 
observed at day 6 post-injection [47]. 
In addition to the question of what stimuli lead to suprabasal 
integrin expression, there are questions as to the nature and 
function of the receptors. We need to discover whether the 
presence of suprabasal receptors reflects de n.ovo integrin synthesis 
by differentiating keratinocytes or an increase in the half-life of 
receptors synthesized in the basal layer [12]. At least in ViIlO, there 
is no evidence for co-localization of the supra basal integrins with 
the ECM proteins that are their ligands [22], thus opening the 
possibility that their primary function is in intercellular adhesion 
[15] or that the receptors are inactive [2,59]. 
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